BioSpace
AUGUST 30, 2020
When Bionano Genomics acquired Lineagen, Inc. in August, the genomic analysis company gained the final piece it needed to provide comprehensive structural variation detection for researchers and drug developers and a reimbursement pathway for clinicians who want to use its technology to replace c.
Scienmag
AUGUST 30, 2020
Cacao in Colombia is not a major driver of deforestation — yet; new research shows cacao stakeholders have to overcome barriers to reach markets that value zero-deforestation, complicating one of Colombia’s post-conflict strategies Credit: Neil Palmer / International Center for Tropical Agriculture When Brazil refused soy grown on deforested land in the Amazon, the movement […].
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
BioSpace
AUGUST 30, 2020
Vir Biotechnology and GlaxoSmithKline dosed the first patient last week in a Phase II/III clinical trial of VIR-7831, a fully human monoclonal antibody against COVID-19.
Scienmag
AUGUST 30, 2020
Sophia Antipolis, France – 31 Aug 2020: There is no evidence that blood pressure lowering drugs increase the risk of cancer, according to the most extensive study conducted on the topic. The late breaking research is presented today at ESC Congress 2020.1 “Our results should reassure the public about the safety of antihypertensive drugs with […].
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
BioSpace
AUGUST 30, 2020
On Sunday, U.S. Food and Drug Administration Commissioner Stephen Hahn told the Financial Times that he would potentially fast-track a COVID-19 vaccine before clinical trials are done if it was “appropriate.
JAMA Internal Medicine
AUGUST 30, 2020
This cohort study examines the association between cell phone location and the rate of change in new COVID-19 cases by county across the US.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
Scienmag
AUGUST 30, 2020
Credit: Kreshuk group/EMBL and Hamprecht lab/HCI Heidelberg University Imagine working on a jigsaw puzzle with so many pieces that even the edges seem indistinguishable from others at the puzzle’s centre. The solution seems nearly impossible. And, to make matters worse, this puzzle is in a futuristic setting where the pieces are not only numerous, but […].
BioSpace
AUGUST 30, 2020
As August wraps up, there were still clinical trial announcements, although fewer than earlier this summer. Here’s a look.
Scienmag
AUGUST 30, 2020
Credit: APS Linguistic researchers use an extensive body of research on English and other Western languages to make broad assumptions about trends in human language, including an apparent universal preference for suffixes (e.g., less, able, ment) over prefixes (e.g., fore, anti, trans). Since psychological scientists recognize the powerful link between language and cognition, a tendency […].
BioSpace
AUGUST 30, 2020
Jayson Dallas, president and chief executive officer of Aimmune, said the agreement with Nestlé recognizes the value of Aimmune’s longtime commitment to advancing therapies for food allergies.
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
JAMA Internal Medicine
AUGUST 30, 2020
This essay discusses the need for more diversity in the physician workforce to benefit patients and society.
BioSpace
AUGUST 30, 2020
AstraZeneca’s Farxiga (dapagliflozin) dramatically prolonged survival in patients with chronic kidney disease in a Phase III clinical trial.
BioTech 365
AUGUST 30, 2020
FARXIGA is the first medicine to significantly prolong survival in a renal outcomes trial in patients with chronic kidney disease with and without type 2 diabetes WILMINGTON, Del.
BioSpace
AUGUST 30, 2020
Shares of Akcea Therapeutics were up more than 58% in premarket trading after its majority owner Ionis Pharmaceuticals announced it will acquire all outstanding shares of the company, which amounts to about 24% of available stock for $18.50 per share.
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
Scienmag
AUGUST 30, 2020
Sophia Antipolis, France – 30 Aug 2020: Premenopausal women have good long-term outcomes after a heart attack, according to late breaking research presented today at ESC Congress 2020.1 “Previous research has shown that women are more likely to die after a heart attack than men,” said principal investigator Professor Diego Ardissino of Parma University Hospital, […].
BioSpace
AUGUST 30, 2020
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for August 31, 2020.
BioTech 365
AUGUST 30, 2020
Not for distribution to United States newswire services or for dissemination in the United States. All figures in Canadian dollars unless otherwise specified. LOS ANGELES, Aug. 30, 2020 (GLOBE NEWSWIRE) — Ventura Cannabis and Wellness Corp.
BioTech 365
AUGUST 30, 2020
— Supplemental NDAs for Toripalimab filed— Expanding into infectious disease and collaborating with IMCAS and Lilly for COVID-19 neutralizing antibodies— Dual Listing on the STAR Market SHANGHAI, China, Aug.
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
BioTech 365
AUGUST 30, 2020
AU $325.00End Date: Friday Sep-4-2020 21:47:46 ESTBuy It Now for only: AU $325.00Buy It Now | Add to watch list Biotech365 : Eppendorf Research Plus Variable Volume Single-channel Pipette 0.
BioTech 365
AUGUST 30, 2020
EUR 60,00 (0 Offerte)Scadenza: lunedì ago-31-2020 19:38:36 CESTFai un’offerta | Aggiungi all’elenco degli oggetti che osservi Biotech365 : Eppendorf Research Single Channel Adjustable Volume 1000 BioMarketplace You want to propose your products or a Biotech Company, a Biotech Tool or … Continue reading →
BioTech 365
AUGUST 30, 2020
CHF 813,69Angebotsende: Mittwoch Sep-30-2020 0:17:23 CESTSofort-Kaufen für nur: CHF 813,69Sofort-Kaufen | Zur Liste der beobachteten Artikel hinzufügen Biotech365 : NIB SHIMADZU 228-33843-91 FLOW CELL ASSEMBLY, RF-10AXL, 2283384391 BioMarketplace You want to propose your products or a Biotech Company, a Biotech … Continue reading →
BioTech 365
AUGUST 30, 2020
CHF 14,45Angebotsende: Montag Sep-21-2020 16:15:57 CESTSofort-Kaufen für nur: CHF 14,45Sofort-Kaufen | Zur Liste der beobachteten Artikel hinzufügen Biotech365 : Set of 4 High Quality Glass Filters for Biological Microscope 30mm or 32mm BNC BioMarketplace You want to propose your products … Continue reading →
Advertisement
As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.
BioTech 365
AUGUST 30, 2020
Pooled data from Phase III ORION-10 and -11 showed highly consistent efficacy, tolerability and safety profile over 17 months on twice-yearly subcutaneous dosing in 2,300 patients (of which 1,164 were on inclisiran) 1 New post-hoc analysis demonstrates 99% of patients … Continue reading →
BioTech 365
AUGUST 30, 2020
EUR 350,00Scadenza: martedì set-29-2020 18:28:20 CESTCompralo Subito per soli: EUR 350,00Compralo Subito | Aggiungi all’elenco degli oggetti che osservi Biotech365 : Agilent 34401A Digital Multimeter 6½ digit resolution BioMarketplace You want to propose your products or a Biotech Company, a … Continue reading →
BioTech 365
AUGUST 30, 2020
257,70 EURFecha de finalización: martes sep-29-2020 16:02:08 CESTCómpralo ya por sólo: 257,70 EUR¡Cómpralo ya! | Añadir a lista de seguimiento Biotech365 : 2020 Black 3.
BioTech 365
AUGUST 30, 2020
31.764,49 EURDate de fin: jeudi sept.-24-2020 20:01:27 CESTAchat immédiat pour seulement: 31.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
BioTech 365
AUGUST 30, 2020
2.235,28 EURDate de fin: mardi sept.-8-2020 16:34:12 CESTAchat immédiat pour seulement: 2.
BioTech 365
AUGUST 30, 2020
CHF 1.359,77Angebotsende: Sonntag Sep-6-2020 22:30:50 CESTSofort-Kaufen für nur: CHF 1.
BioTech 365
AUGUST 30, 2020
$250.00End Date: Wednesday Sep-30-2020 5:57:21 PDTBuy It Now for only: $250.
BioTech 365
AUGUST 30, 2020
$179.99End Date: Sunday Sep-27-2020 13:20:34 PDTBuy It Now for only: $179.
Advertisement
The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.
Expert insights. Personalized for you.
133 
Let's personalize your content